(Q46163207)

English

The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit

scientific article published on 14 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

Robert A Kloner

2

object named as

Robert A Kloner

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

author name string

Sharon L Hale

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

publication date

14 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

13

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

226-232

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F1074248408320278

21 January 2018

Identifiers

10.1177/1074248408320278

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18625805

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46163207&oldid=2096356583"